US 9115120
Heterocyclic modulators of HIF activity for treatment of disease
granted A61KA61K31/4245A61K31/454
Quick answer
US patent 9115120 (Heterocyclic modulators of HIF activity for treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/4245, A61K31/454, A61K31/496, A61K31/5377